Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (501-510 of 684) with videos related to

Pageof 69
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2011
BAD phosphorylation determines ovarian cancer chemosensitivity and patient survivalDouglas C Marchion, Hope M Cottrill, Yin Xiong, et al.
JAMA Network Open|April 28, 2025
Development of Common Data Elements for Organ TransplantationLisa M McElroy, Ursula Rogers, Liz Nichols, et al.
JCO Precision Oncology|November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate CancerFadi Taza, Albert E Holler, Wei Fu, et al.
NPJ Precision Oncology|July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancerKarl Semaan, Rashad Nawfal, John Canniff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian CarcinomaLauren C Peres, Christelle Colin-Leitzinger, Sweta Sinha, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2016
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility LociBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
British Journal of Cancer|July 18, 2024
Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Elisa V Bandera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA ProfilingTalal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Pageof 69

Showing results (501-510 of 684) with videos related to

Sort By:
Pageof 69
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2011
BAD phosphorylation determines ovarian cancer chemosensitivity and patient survivalDouglas C Marchion, Hope M Cottrill, Yin Xiong, et al.
JAMA Network Open|April 28, 2025
Development of Common Data Elements for Organ TransplantationLisa M McElroy, Ursula Rogers, Liz Nichols, et al.
JCO Precision Oncology|November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate CancerFadi Taza, Albert E Holler, Wei Fu, et al.
NPJ Precision Oncology|July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancerKarl Semaan, Rashad Nawfal, John Canniff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian CarcinomaLauren C Peres, Christelle Colin-Leitzinger, Sweta Sinha, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2016
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility LociBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
British Journal of Cancer|July 18, 2024
Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Elisa V Bandera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA ProfilingTalal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Pageof 69